Titan International, Inc.
NYSE:TWIAgricultural - Machinery
+$0.24 today
- Market cap
- $283.62M
- Beta
- 1.47
- P/E (TTM)
- -5.6
- EPS (TTM)
- -$1.36
Volume 0.77M
Average 0.93M
TWI Stock-Based Compensation
Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.
Titan International, Inc.NYSE: TWI
Stock-Based Compensation · Q1 FY2026 · quarter ended Mar 2026
Stock-based compensation turns positive
Q1 FY2026 stock-based compensation was $0, compared with -$925K a year earlier. Trailing-twelve-month stock-based compensation was $1.4M.
Context
- Stock-based compensation amounted to 0.0% of revenue in FY2025, down 0.3 pp from a year earlier.
- Stock-based compensation increased in 2 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly stock-based compensation holds near $0 or moves back toward the trailing-twelve-month quarterly average of $351K.
Sources:Cash FlowText generated from reported figures; not investment advice.
Stock-Based Compensation history
USD · from the cash flow
- Latest · FY2025
- 0 USD
- Year-over-year change
- -100.0%
| Period | Period end | Stock-Based Compensation | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | -100.0% |
| FY2024 | 2024-12-31 | 5.4M | +3.2% |
| FY2023 | 2023-12-31 | 5.24M | +22.3% |
| FY2022 | 2022-12-31 | 4.28M | +24.4% |
| FY2021 | 2021-12-31 | 3.44M | — |
Stock-Based Compensation vs competitors
How TWI compares with its peers on the latest reported figures
- TWI's LTM Mar 2026 stock-based compensation of $1.4M is the 9th largest of the 11 companies compared; the peer median is $7.29M.
- Its year-over-year change of -68.4% is the 7th highest of 9, against a peer median of -4.0%.
- Stock-based compensation amounts to 0.1% of revenue for TWI, versus a peer median of 0.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $40.05M | — | +91.2% | 45.5% | |
| LTM Mar 2026 | $14.68M | -13.0% | +15.3% | 0.8% | |
| LTM Mar 2026 | $12.35M | +97.5% | -2.8% | 1.0% | |
| LTM Mar 2026 | $9.7M | -1.0% | +3.8% | 0.4% | |
| LTM Mar 2026 | $8M | +60.0% | +0.0% | 0.7% | |
SRTAStrata Critical Medical, Inc. | LTM Mar 2026 | $6.59M | +21.9% | +29.2% | 2.6% |
| LTM Mar 2026 | $4.96M | -71.4% | -18.1% | 2.7% | |
| LTM Mar 2026 | $3.49M | -7.0% | -18.5% | 0.3% | |
| LTM Mar 2026 | $1.4M | -68.4% | — | 0.1% | |
| LTM Mar 2026 | $531K | -88.1% | -2.8% | 0.2% | |
| LTM Dec 2025 | $0 | — | — | 0.0% | |
| Peer median (excluding TWI) | $7.29M | -4.0% | +0.0% | 0.8% | |
Competitors are the stored peer set for TWI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 49.89M | 179.19M | 83.71M | (3.59M) | (63.49M) |
| Depreciation & Amortization | 47.99M | 42.75M | 42.43M | 60.7M | 67.11M |
| Deferred Income Tax | (14.18M) | (55.43M) | (2.08M) | (6.36M) | 30.99M |
| Stock-Based Compensation | 3.44M | 4.28M | 5.24M | 5.4M | 0 |
| Change in Working Capital | (84.17M) | (25.07M) | 32.29M | 88.47M | (21.76M) |
| Accounts Receivables | (74.74M) | (27.2M) | 42.87M | 73.83M | (3.98M) |
| Inventory | (112.85M) | (19.6M) | 31.64M | 51.48M | (7.12M) |
| Accounts Payables | 121.19M | (7.75M) | (62.73M) | (29.17M) | 11.3M |
| Other Working Capital | (17.78M) | 29.48M | 20.51M | (7.67M) | (21.97M) |
| Other Non-Cash Items | 7.76M | 14.96M | 17.77M | (3.14M) | 17.19M |
| Operating Cash Flow | 10.73M | 160.68M | 179.35M | 141.49M | 30.03M |
| Capital Expenditures | (38.8M) | (46.97M) | (60.8M) | (65.62M) | (54.62M) |
| Acquisitions (Net) | 0 | 9.29M | 0 | (143.64M) | 0 |
| Purchases of Investments | 0 | (9.29M) | 0 | 0 | 0 |
| Sales of Investments | 0 | 9.29M | 2.09M | 1.79M | 0 |
| Other Investing Activities | 1.2M | 930K | 1.79M | 5.88M | (5.03M) |
| Investing Cash Flow | (37.6M) | (36.75M) | (56.92M) | (201.6M) | (59.65M) |
| Debt Repayment | 14.97M | (35.8M) | (20.94M) | 142.91M | 17.44M |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | (25M) | (32.58M) | (74.02M) | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (1.02M) | (511K) | (2.5M) | (4.34M) | 6K |
| Financing Cash Flow | 13.95M | (61.31M) | (56.02M) | 64.55M | 17.45M |
| Effect of Forex Changes | (6.4M) | (1.15M) | (5.74M) | (28.72M) | 19.08M |
| Net Change in Cash | (19.32M) | 61.47M | 60.67M | (24.28M) | 6.91M |
| Free Cash Flow | (28.08M) | 113.7M | 118.55M | 75.86M | (24.59M) |
Titan International, Inc.
NYSE:TWI
Intrinsic Alpha fair value
Locked
Current Price
$4.39
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.